The elevation of circulating fibroblast growth factor 23 without kidney disease does not increase cardiovascular disease risk - Concepedia

Concepedia

Publication | Open Access

The elevation of circulating fibroblast growth factor 23 without kidney disease does not increase cardiovascular disease risk

DOI Full Paper Access

75

Citations

39

References

2018

Year

Eva‐María Pastor‐Arroyo, Nicole Gehring, Christiane Krudewig, Sarah Costantino, Carla Bettoni, Thomas Knöpfel, Sibylle Sabrautzki, Bettina Lorenz‐Depiereux, Johanne Pastor, Tim M. Strom,

Kidney International

Metabolic SyndromeFibrosisCardiovascular DiseaseMedicinePathologyFibroblast Growth FactorVascular BiologyKidney DiseaseMicrovascular DysfunctionChronic Kidney DiseaseAtherosclerosisNephrologyKidney ResearchCardiovascular Disease Risk

References

	Year	Citations

Page 1

Page 1